cupric chloride has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evangelista, L; Sepulcri, M; Trevisan, M | 1 |
| Cai, H; Hsieh, JT; Lee, RJ; Muzik, O; Peng, F; Wu, JS | 1 |
| Capasso, E; Durzu, S; Hacker, M; Haug, A; Knoll, P; Meleddu, C; Mirzaei, S; Piras, S; Zandieh, S | 1 |
3 other study(ies) available for cupric chloride and Cancer of Prostate
| Article | Year |
|---|---|
64CuCl2 PET/CT in a Hyperfunctioning Parathyroid Gland.
Topics: Copper; Humans; Incidental Findings; Male; Middle Aged; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
Topics: Animals; Blotting, Western; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Copper; Copper Radioisotopes; Copper Transporter 1; Genetic Vectors; Humans; Lentivirus; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; RNA, Small Interfering; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Role of (64)CuCl 2 PET/CT in staging of prostate cancer.
Topics: Aged; Aged, 80 and over; Copper; Copper Radioisotopes; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |